$NVAX
NOVAVAX INC Stock $nvax

$nvax Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000114420414014965 Filed on March 12, 2014

Income Statement

Concept	2014 Q1	2012 Q4	2012 Q3
Revenue	$7.462M	$4.567M	$5.765M
YoY Change	94.68%	-21.86%	15.12%
Cost Of Revenue	$3.021M	$2.000M	$3.838M
YoY Change	76.46%	-37.5%	75.25%
Gross Profit	$4.441M	$2.600M	$1.927M
YoY Change	109.38%	0.0%	-31.62%
Gross Profit Margin	59.51%	56.93%	33.43%
Selling, General & Admin	$4.300M	$2.500M	$2.100M
YoY Change	48.28%	0.0%	-22.22%
% of Gross Profit	96.83%	96.15%	108.98%
Research & Development	$14.52M	$9.600M	$6.642M
YoY Change	56.85%	118.18%	64.04%
% of Gross Profit	326.91%	369.23%	344.68%
Depreciation & Amortization	$1.000M	$500.0K	$400.0K
YoY Change	150.0%	25.0%	0.0%
% of Gross Profit	22.52%	19.23%	20.76%
Operating Expenses	$14.52M	$12.10M	$6.642M
YoY Change	56.85%	75.36%	64.04%
Operating Profit	-$14.39M	-$9.500M	-$6.849M
YoY Change	43.78%	120.93%	72.61%
Interest Expense	$52.00K	$1.400M	$6.000K
YoY Change	136.36%	180.0%	200.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$0.00
YoY Change
Pretax Income	-$13.81M	-$8.000M	-$7.217M
YoY Change	38.39%	116.22%	124.69%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$13.81M	-$8.000M	-$7.217M
YoY Change	38.16%	116.22%	124.69%
Net Earnings / Revenue	-185.07%	-175.17%	-125.19%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.327M	-$1.194M	-$1.075M
COMMON SHARES
Basic Shares Outstanding	209.1M shares	147.9M	133.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2012 Q4	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$112.8M	$44.10M	$28.40M
YoY Change	154.63%	140.98%	44.9%
Cash & Equivalents	$109.9M	$17.40M	$10.74M
Short-Term Investments	$2.900M	$26.70M	$17.70M
Other Short-Term Assets	$504.0K	$171.0K	$235.0K
YoY Change	-43.12%	-89.02%	-91.61%
Inventory
Prepaid Expenses	$4.626M	$2.559M	$2.807M
Receivables	$4.466M	$1.011M	$2.469M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$128.9M	$50.41M	$36.48M
YoY Change	149.16%	93.07%	38.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.27M	$11.46M	$9.815M
YoY Change	22.84%	67.07%	30.87%
Goodwill	$58.62M	$33.14M	$33.14M
YoY Change	76.88%	0.0%
Intangibles	$15.92M	$0.00
YoY Change
Long-Term Investments		$6.200M
YoY Change
Other Assets	$159.0K	$351.0K	$350.0K
YoY Change	-54.57%	-25.16%	75.0%
Total Long-Term Assets	$89.73M	$51.94M	$44.06M
YoY Change	90.98%	28.34%	8.0%
TOTAL ASSETS
Total Short-Term Assets	$128.9M	$50.41M	$36.48M
Total Long-Term Assets	$89.73M	$51.94M	$44.06M
Total Assets	$218.6M	$102.3M	$80.55M
YoY Change	121.47%	53.73%	20.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.018M	$3.228M	$2.203M
YoY Change	84.91%	22.04%	-8.21%
Accrued Expenses	$8.208M	$7.275M	$6.031M
YoY Change	40.5%	60.67%	54.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	-$157.0K	$0.00
YoY Change		685.0%
Long-Term Debt Due	$1.000M	$200.0K	$200.0K
YoY Change	150.0%
Total Short-Term Liabilities	$13.72M	$11.68M	$10.44M
YoY Change	48.22%	54.04%	55.84%
LONG-TERM LIABILITIES
Long-Term Debt	$1.100M	$1.000M	$1.000M
YoY Change	-26.67%	233.33%	233.33%
Other Long-Term Liabilities	$1.562M		$7.700M
YoY Change	-84.98%		42.59%
Total Long-Term Liabilities	$1.562M	$0.00	$8.700M
YoY Change	-86.87%	-100.0%	52.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.72M	$11.68M	$10.44M
Total Long-Term Liabilities	$1.562M	$0.00	$8.700M
Total Liabilities	$27.54M	$22.11M	$19.17M
YoY Change	30.29%	73.69%	53.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$424.0M	-$358.2M	-$350.1M
YoY Change	15.16%	8.65%
Common Stock	$2.097M	$1.484M	$1.360M
YoY Change	38.23%	26.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.450M	$2.450M	$2.450M
YoY Change	0.0%	0.0%
Treasury Stock Shares	455.4K shares	455.4K shares	$455.4K
Shareholders Equity	$191.1M	$80.24M	$61.38M
YoY Change
Total Liabilities & Shareholders Equity	$218.6M	$102.3M	$80.55M
YoY Change	121.47%	53.73%	20.04%

Cashflow Statement

Concept	2014 Q1	2012 Q4	2012 Q3
OPERATING ACTIVITIES
Net Income	-$13.81M	-$8.000M	-$7.217M
YoY Change	38.16%	116.22%	124.69%
Depreciation, Depletion And Amortization	$1.000M	$500.0K	$400.0K
YoY Change	150.0%	25.0%	0.0%
Cash From Operating Activities	-$20.43M	-$3.200M	-$4.700M
YoY Change	93.05%	14.29%	38.24%
INVESTING ACTIVITIES
Capital Expenditures	-$900.0K	-$2.100M	-$1.100M
YoY Change	-40.0%	950.0%	450.0%
Acquisitions
YoY Change
Other Investing Activities	$10.60M	-$15.00M	-$6.200M
YoY Change	-411.76%	-1600.0%	-258.97%
Cash From Investing Activities	$9.701M	-$17.20M	-$7.300M
YoY Change	-295.03%	-2250.0%	-302.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$26.90M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.170M	27.00M	7.400M
YoY Change	-83.71%	1400.0%	722.22%
NET CHANGE
Cash From Operating Activities	-$20.43M	-3.200M	-4.700M
Cash From Investing Activities	$9.701M	-17.20M	-7.300M
Cash From Financing Activities	$1.170M	27.00M	7.400M
Net Change In Cash	-$9.560M	6.600M	-4.600M
YoY Change	14.14%	-3400.0%	-518.18%
FREE CASH FLOW
Cash From Operating Activities	-$20.43M	-$3.200M	-$4.700M
Capital Expenditures	-$900.0K	-$2.100M	-$1.100M
Free Cash Flow	-$19.53M	-$1.100M	-$3.600M
YoY Change	115.03%	-57.69%	12.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001000694
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	209056800	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	246500000	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	NOVAVAX INC
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2013	dei	Trading Symbol TradingSymbol	NVAX
CY2012	nvax	Business Acquisition Pro Forma Earnings Per Share Basic And Diluted BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted	-0.24
CY2012	nvax	Deposits For Acquisition Of Property And Equipment DepositsForAcquisitionOfPropertyAndEquipment	500000	USD
CY2013	nvax	Acquisition Transaction Costs AcquisitionTransactionCosts	1300000	USD
CY2013Q4	nvax	Additional Tenant Improvement Allowance AdditionalTenantImprovementAllowance	3000000	USD
CY2013Q4	nvax	Aggregate Payments Made Per License Agreement AggregatePaymentsMadePerLicenseAgreement	5900000	USD
CY2013	nvax	Business Acquisition Pro Forma Earnings Per Share Basic And Diluted BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted	-0.31
CY2013Q3	nvax	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill	26236000	USD
CY2011	nvax	Cancellation Of Previously Issued Common Stock Value CancellationOfPreviouslyIssuedCommonStockValue	50000	USD
CY2013	nvax	Capital Lease Obligation Equipment Purchased CapitalLeaseObligationEquipmentPurchased		USD
CY2012	nvax	Capital Lease Obligation Equipment Purchased CapitalLeaseObligationEquipmentPurchased	399000	USD
CY2011	nvax	Capital Lease Obligation Equipment Purchased CapitalLeaseObligationEquipmentPurchased		USD
CY2013Q4	nvax	Contingent Payment Amount ContingentPaymentAmount	14000000	USD
CY2012Q3	nvax	Debt Instrument Term Extended DebtInstrumentTermExtended	P42M
CY2013Q4	nvax	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	142531000	USD
CY2012Q4	nvax	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	135415000	USD
CY2013	nvax	Defined Contribution Plan Cost And Other Expenses DefinedContributionPlanCostAndOtherExpenses	200000	USD
CY2013	nvax	Defined Contribution Plan Percent Of Employee Deferral Eligible For Employer Matching DefinedContributionPlanPercentOfEmployeeDeferralEligibleForEmployerMatching	0.06	pure
CY2013	nvax	Deposits For Acquisition Of Property And Equipment DepositsForAcquisitionOfPropertyAndEquipment		USD
CY2011	nvax	Deposits For Acquisition Of Property And Equipment DepositsForAcquisitionOfPropertyAndEquipment		USD
CY2013Q4	nvax	Joint Venture Percentage Owned By Others JointVenturePercentageOwnedByOthers	0.2	pure
CY2013Q4	nvax	Loan Agreement Future Minimum Payments Due LoanAgreementFutureMinimumPaymentsDue	1881000	USD
CY2013Q4	nvax	Loan Agreement Future Minimum Payments Due In Rolling Year Three LoanAgreementFutureMinimumPaymentsDueInRollingYearThree	396000	USD
CY2013Q4	nvax	Loan Agreement Future Minimum Payments Due In Rolling Year Two LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo	608000	USD
CY2013Q4	nvax	Loan Agreement Future Minimum Payments Next Rolling Twelve Months LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths	877000	USD
CY2013Q3	nvax	Novavax Shares Issued NovavaxSharesIssued	15600000	shares
CY2011	nvax	Research And Development Collaboration ResearchAndDevelopmentCollaboration		USD
CY2013	nvax	Proceeds From Issuance Or Sale Of Equity Not Settled ProceedsFromIssuanceOrSaleOfEquityNotSettled		USD
CY2012	nvax	Proceeds From Issuance Or Sale Of Equity Not Settled ProceedsFromIssuanceOrSaleOfEquityNotSettled		USD
CY2011	nvax	Proceeds From Issuance Or Sale Of Equity Not Settled ProceedsFromIssuanceOrSaleOfEquityNotSettled	847000	USD
CY2013Q4	nvax	Purchase Commitment Aggregate Amount Incurred Towards Total Commitment PurchaseCommitmentAggregateAmountIncurredTowardsTotalCommitment	3000000	USD
CY2013Q4	nvax	Purchase Obligation Minimum Payment Threshold PurchaseObligationMinimumPaymentThreshold	2000000	USD
CY2013Q4	nvax	Purchase Obligation Percent Of Shortfall PurchaseObligationPercentOfShortfall	0.5	pure
CY2013Q4	nvax	Purchase Obligation Remaining Obligation PurchaseObligationRemainingObligation	4500000	USD
CY2012	nvax	Reclassification From General Administrative Expenses To Research Development Expenses ReclassificationFromGeneralAdministrativeExpensesToResearchDevelopmentExpenses	800000	USD
CY2011	nvax	Reclassification From General Administrative Expenses To Research Development Expenses ReclassificationFromGeneralAdministrativeExpensesToResearchDevelopmentExpenses	500000	USD
CY2013Q4	nvax	Research And Development Accruals ResearchAndDevelopmentAccruals	4469000	USD
CY2012Q4	nvax	Research And Development Accruals ResearchAndDevelopmentAccruals	3396000	USD
CY2013	nvax	Research And Development Collaboration ResearchAndDevelopmentCollaboration	3207000	USD
CY2012	nvax	Research And Development Collaboration ResearchAndDevelopmentCollaboration	1405000	USD
CY2013	nvax	Settlement Of Notes Receivable SettlementOfNotesReceivable		USD
CY2012	nvax	Settlement Of Notes Receivable SettlementOfNotesReceivable		USD
CY2011	nvax	Settlement Of Notes Receivable SettlementOfNotesReceivable	1522000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7154000	USD
CY2011	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-317000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11223000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7275000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9420000	USD
CY2013Q4	nvax	Tenant Improvement Allowance TenantImprovementAllowance	2500000	USD
CY2013Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	11223000	USD
CY2012Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	7275000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5985000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3228000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1911000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1011000	USD
CY2013	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-507000	USD
CY2012	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	18000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	839000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	430000	USD
CY2013	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P17Y
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2091000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2047000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	6067000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	365000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	246000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2480000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	612900000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	438939000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2480000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2091000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2047000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11992918	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12732383	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11284054	shares
CY2013	us-gaap	Asset Impairment Charges AssetImpairmentCharges		USD
CY2012	us-gaap	Asset Impairment Charges AssetImpairmentCharges		USD
CY2011	us-gaap	Asset Impairment Charges AssetImpairmentCharges	360000	USD
CY2013Q4	us-gaap	Assets Assets	235937000	USD
CY2012Q4	us-gaap	Assets Assets	102345000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	145001000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	50408000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	13597000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	32945000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	12981000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	32515000	USD
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	13597000	USD
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	26712000	USD
CY2013	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	616000	USD
CY2012	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	430000	USD
CY2013	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss		USD
CY2012	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss		USD
CY2013Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent		USD
CY2012Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	6233000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-55594000	USD
CY2012	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-35042000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	22785000	USD
CY2012	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	24810000	USD
CY2013Q3	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	41964000	USD
CY2013Q3	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	41942000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation	94000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	3056000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	1092000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	447000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	3806000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	16620000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt	193000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther	1559000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	165000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	41964000	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	379000	USD
CY2012	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1321000	USD
CY2011	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	14000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	108000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	58000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	195000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	237000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	338000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	122000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Four CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour	47000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Three CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree	84000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Two CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo	85000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	35000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	303000	USD
CY2013Q4	us-gaap	Cash Cash	4251000	USD
CY2012Q4	us-gaap	Cash Cash	3758000	USD
CY2013	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3034000	USD
CY2012	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		USD
CY2011	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119471000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17399000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14104000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8061000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	102072000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3295000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6043000	USD
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2008Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	3.62
CY2013Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0.5	shares
CY2008Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3343325	shares
CY2013Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	15171000	USD
CY2012Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	209110744	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	148398747	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	208655314	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	147943317	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	2091000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	1484000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51574000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28909000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19304000	USD
CY2013	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	-200000	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="MIN-WIDTH: 708px; TEXT-ALIGN: center"> <!--StartFragment--> <h3 style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 5pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 24px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 0pt"> Concentration of Credit Risk</h3> <p style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 3pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 4px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 20px"> Financial instruments, which possibly expose the Company to concentration of credit risk, consist primarily of cash and cash equivalents and investments. The Company's investment policy limits investments to certain types of instruments, including auction rate securities, high-grade corporate debt securities and money market instruments, places restrictions on maturities and concentrations in certain industries and requires the Company to maintain a certain level of liquidity. At times, the Company maintains cash balances in financial institutions, which may exceed federally insured limits. The Company has not experienced any losses relating to such accounts and believes it is not exposed to a significant credit risk on its cash and cash equivalents. As discussed below, the fair value of investments is based upon Level 1 and 2 data.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Contract Revenue Cost ContractRevenueCost	8222000	USD
CY2012	us-gaap	Contract Revenue Cost ContractRevenueCost	14692000	USD
CY2011	us-gaap	Contract Revenue Cost ContractRevenueCost	7003000	USD
CY2013	us-gaap	Contracts Revenue ContractsRevenue	17708000	USD
CY2012	us-gaap	Contracts Revenue ContractsRevenue	20671000	USD
CY2011	us-gaap	Contracts Revenue ContractsRevenue	14688000	USD
CY2013	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	41942000	USD
CY2012	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		USD
CY2011	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	73349000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	51741000	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	36267000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	25000	USD
CY2012	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		USD
CY2011	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	412000	USD
CY2012Q3	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.1168	pure
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1881000	USD
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	910000	USD
CY2012	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness		USD
CY2011	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness		USD
CY2012Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2000000	USD
CY2012Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage Rate Range Minimum DebtInstrumentInterestRateStatedPercentageRateRangeMinimum	0.121	pure
CY2012Q3	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	47618	USD
CY2013Q4	us-gaap	Deductions Charges DeductionsCharges	2400000	USD
CY2012Q4	us-gaap	Deductions Charges DeductionsCharges	2400000	USD
CY2012Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	335000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	470000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3800000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2012Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	432000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8502000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	6940000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	271000	USD
CY2013	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2591000	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1666000	USD
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1613000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7326000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	9175000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5693000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142531000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	135415000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	227000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	335000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2600000	USD
CY2013	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.5	pure
CY2012	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.25	pure
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1700000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	258000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2500000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-3573000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets		USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	146331000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	135750000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	123907000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	122731000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	6405000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign		USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6844000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1600000	USD
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		USD
CY2012Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	267000	USD
CY2013Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	400000	USD
CY2012Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	100000	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.06	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.1	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.03	pure
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	-0.34	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	-0.34	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	-0.34	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.41	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.33	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.43	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.03	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.03	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.03	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.08	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.09	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.07	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05	pure
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	4000	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents		USD
CY2011	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents		USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5323000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3242000	USD
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4600000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
CY2011	us-gaap	Investment Income Net InvestmentIncomeNet	136000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	463000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1111000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1111000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1111000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1111000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1111000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16713000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16250000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	33141000	USD
CY2012Q4	us-gaap	Government Contract Receivable Unbilled Amounts GovernmentContractReceivableUnbilledAmounts	1570000	USD
CY2013	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	267000	USD
CY2012	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	101000	USD
CY2011	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2474000	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	32000	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	28000	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14819000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10142000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10900000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	59519000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	33141000	USD
CY2013	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	26236000	USD
CY2012	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		USD
CY2013	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	142000	USD
CY2012	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments		USD
CY2013Q4	us-gaap	Government Contract Receivable Unbilled Amounts GovernmentContractReceivableUnbilledAmounts	4988000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-51958000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-28507000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18952000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	412000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4184000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2009000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2686000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	451000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-954000	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1911000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-341000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	258000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2500000	USD
CY2013	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	703000	USD
CY2012	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	4346000	USD
CY2011	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-402000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-40000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1854000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	431000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	986000	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash		USD
CY2013	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	3418000	USD
CY2012	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-266000	USD
CY2011	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	1836000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16250000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		USD
CY2013	us-gaap	Interest Expense InterestExpense	160000	USD
CY2012	us-gaap	Interest Expense InterestExpense	32000	USD
CY2011	us-gaap	Interest Expense InterestExpense	9000	USD
CY2013	us-gaap	Interest Paid InterestPaid	177000	USD
CY2012	us-gaap	Interest Paid InterestPaid	20000	USD
CY2011	us-gaap	Interest Paid InterestPaid		USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	75000	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	45000	USD
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	187000	USD
CY2012	us-gaap	Investment Income Net InvestmentIncomeNet	165000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-32262000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	18543000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-45359000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	32703000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	22105000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	235937000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	102345000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18934000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11675000	USD
CY2013	us-gaap	License Costs LicenseCosts	200000	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1004000	USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	753000	USD
CY2013	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		USD
CY2012	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	879000	USD
CY2011	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		USD
CY2013Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	100049000	USD
CY2012Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	11970000	USD
CY2013Q4	us-gaap	Municipal Debt Securities At Carrying Value MunicipalDebtSecuritiesAtCarryingValue		USD
CY2012Q4	us-gaap	Municipal Debt Securities At Carrying Value MunicipalDebtSecuritiesAtCarryingValue	1671000	USD
CY2013	us-gaap	Nature Of Operations NatureOfOperations	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="MIN-WIDTH: 708px; TEXT-ALIGN: center"> <!--StartFragment--> <h2 style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 5pt; FONT: bold 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 4px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 0pt"> Note 1 - Organization</h2> <p style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 3pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 4px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 20px"> Novavax, Inc. ("Novavax," and together with its subsidiary, "Novavax AB," the "Company") is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant protein nanoparticle vaccines and adjuvants. The Company's product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for seasonal influenza, pandemic influenza and respiratory syncytial virus ("RSV").</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	131035000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	53786000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	11129000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	16392000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15300000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1356000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	592000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-18229000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-23629000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-51983000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-28507000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-19364000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9996000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12633000	USD
CY2013Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14054000	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7336000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5920000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7217000	USD
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8035000	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent	877000	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	157000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-52434000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-29665000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-21579000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	32172000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4327000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2429000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2901000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4944000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4912000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	12659000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	3400000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	3200000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1600000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	573000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	171000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	159000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	351000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	223000	USD
CY2012	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		USD
CY2011	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	223000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	409000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-402000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	186000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-402000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	60000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	60000	USD
CY2012	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-45000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1568000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		USD
CY2011	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	341000	USD
CY2013	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-182000	USD
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-897000	USD
CY2012	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-660000	USD
CY2013Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1290000	USD
CY2012Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	967000	USD
CY2011	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-26000	USD
CY2013	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	700000	USD
CY2013	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6100000000	USD
CY2012	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	400000000	USD
CY2011	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	200000000	USD
CY2013	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	14754000	USD
CY2012	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	48652000	USD
CY2011	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2082000	USD
CY2013Q3	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	22000	USD
CY2013	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5785000	USD
CY2012	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4341000	USD
CY2011	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	610000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3044000	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2559000	USD
CY2013	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="MIN-WIDTH: 708px; TEXT-ALIGN: center"> <!--StartFragment--> <h3 style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 5pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 24px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 0pt"> Reclassifications</h3> <p style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 3pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 4px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 20px"> Overhead expenses relating to supply chain management of $0.8 million for 2012 and $0.5 million for 2011 have been reclassified from general and administrative expenses to research and development expenses. This reclassification has been made to conform to current year presentation.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	128648000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	54002000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10980000	USD
CY2013	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1500000	USD
CY2012	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	500000	USD
CY2008Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	17500000	USD
CY2013	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1450000	USD
CY2012	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	650000	USD
CY2011	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2013	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
CY2012	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
CY2011	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	50000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23671000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18610000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14251000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11456000	USD
CY2013	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-473000	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	324000	USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1498000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	54000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	179000	USD
CY2012	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-60000	USD
CY2011	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-80000	USD
CY2013	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-1000	USD
CY2012	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-756000	USD
CY2011	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities		USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	33781000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	20407000	USD
CY2011	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	21235000	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	116000	USD
CY2013Q4	us-gaap	Purchase Obligation PurchaseObligation	7500000	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	87000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	104000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations		USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50308000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26907000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18364000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1417000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	986000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	757000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	756000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-410146000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-358163000	USD
CY2013	us-gaap	Revenues Revenues	20915000	USD
CY2012	us-gaap	Revenues Revenues	22076000	USD
CY2011	us-gaap	Revenues Revenues	14688000	USD
CY2013Q1	us-gaap	Revenues Revenues	3833000	USD
CY2013Q2	us-gaap	Revenues Revenues	3531000	USD
CY2013Q3	us-gaap	Revenues Revenues	4802000	USD
CY2013Q4	us-gaap	Revenues Revenues	8748000	USD
CY2012Q1	us-gaap	Revenues Revenues	4642000	USD
CY2012Q2	us-gaap	Revenues Revenues	7103000	USD
CY2012Q3	us-gaap	Revenues Revenues	5765000	USD
CY2012Q4	us-gaap	Revenues Revenues	4567000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2480000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	2091000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.71
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	33334	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.14
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0055	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0048	pure
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2047000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	35000000	USD
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	14200000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	16667	shares
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	600000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.07
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.39
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.39
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	16667	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.39
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7372	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.786	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.81	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.5155	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.755	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.733	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0136	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0154	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0191	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0054	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y4M24D
CY2013Q4	us-gaap	Share Price SharePrice	2.68
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	-877000	USD
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	-157000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	203234000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	80240000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	53849000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	59050000	USD
CY2008Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6686650	shares
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	170590000	USD
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	53155000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11827000	USD
CY2011	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1498000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54000	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	179000	USD
CY2013Q4	us-gaap	Supplies Supplies	1754000	USD
CY2012Q4	us-gaap	Supplies Supplies	1592000	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	455430	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	455430	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2450000	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2450000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4801000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4801000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4875000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	74000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities		USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities		USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="MIN-WIDTH: 708px; TEXT-ALIGN: center"> <!--StartFragment--> <h3 style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 5pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 24px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 0pt"> Use of Estimates</h3> <p style="TEXT-TRANSFORM: none; PADDING-BOTTOM: 3pt; TEXT-ALIGN: left; PADDING-TOP: 3pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-LEFT: 4px; MARGIN: 0pt; PADDING-RIGHT: 0pt; TEXT-INDENT: 20px"> The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	169658	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	131726	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	113610	shares

Files In Submission

Name	View Source	Status
0001144204-14-014965-index-headers.html	Edgar Link	pending
0001144204-14-014965-index.html	Edgar Link	pending
0001144204-14-014965.txt	Edgar Link	pending
0001144204-14-014965-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
line.gif	Edgar Link	pending
nvax-20131231.xml	Edgar Link	completed
nvax-20131231.xsd	Edgar Link	pending
nvax-20131231_cal.xml	Edgar Link	unprocessable
nvax-20131231_def.xml	Edgar Link	unprocessable
nvax-20131231_lab.xml	Edgar Link	unprocessable
nvax-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spacer.gif	Edgar Link	pending
tpg1.jpg	Edgar Link	pending
tpg2.jpg	Edgar Link	pending
tpg3.jpg	Edgar Link	pending
v368962_10k.htm	Edgar Link	pending
v368962_chrt-line.jpg	Edgar Link	pending
v368962_ex10-25.htm	Edgar Link	pending
v368962_ex10-37.htm	Edgar Link	pending
v368962_ex21-1.htm	Edgar Link	pending
v368962_ex23-1.htm	Edgar Link	pending
v368962_ex31-1.htm	Edgar Link	pending
v368962_ex31-2.htm	Edgar Link	pending
v368962_ex32-1.htm	Edgar Link	pending
v368962_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVAX
NOVAVAX INC Stock $nvax

2014 Q1 Form 10-K Financial Statement

#000114420414014965 Filed on March 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVAX NOVAVAX INC Stock $nvax

2014 Q1 Form 10-K Financial Statement

#000114420414014965 Filed on March 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVAX
NOVAVAX INC Stock $nvax